Ratio de rentabilidad sobre el patrimonio neto de los accionistas (ROE)
desde 2005
Cálculo
Abbott Laboratories, ROE, tendencias a largo plazocálculo
| ROE | = | 100 | × | Utilidades netas1 | ÷ | Inversión total de los accionistas de Abbott1 | |
|---|---|---|---|---|---|---|---|
| 31 dic. 2021 | 19.75% | = | 100 | × | 7,071 | ÷ | 35,802 |
| 31 dic. 2020 | 13.71% | = | 100 | × | 4,495 | ÷ | 32,784 |
| 31 dic. 2019 | 11.86% | = | 100 | × | 3,687 | ÷ | 31,088 |
| 31 dic. 2018 | 7.76% | = | 100 | × | 2,368 | ÷ | 30,524 |
| 31 dic. 2017 | 1.54% | = | 100 | × | 477 | ÷ | 30,897 |
| 31 dic. 2016 | 6.82% | = | 100 | × | 1,400 | ÷ | 20,538 |
| 31 dic. 2015 | 20.85% | = | 100 | × | 4,423 | ÷ | 21,211 |
| 31 dic. 2014 | 10.61% | = | 100 | × | 2,284 | ÷ | 21,526 |
| 31 dic. 2013 | 10.23% | = | 100 | × | 2,576 | ÷ | 25,171 |
| 31 dic. 2012 | 22.32% | = | 100 | × | 5,963 | ÷ | 26,721 |
| 31 dic. 2011 | 19.35% | = | 100 | × | 4,728 | ÷ | 24,440 |
| 31 dic. 2010 | 20.66% | = | 100 | × | 4,626 | ÷ | 22,388 |
| 31 dic. 2009 | 25.14% | = | 100 | × | 5,746 | ÷ | 22,856 |
| 31 dic. 2008 | 27.92% | = | 100 | × | 4,881 | ÷ | 17,480 |
| 31 dic. 2007 | 20.28% | = | 100 | × | 3,606 | ÷ | 17,779 |
| 31 dic. 2006 | 12.22% | = | 100 | × | 1,717 | ÷ | 14,054 |
| 31 dic. 2005 | 23.39% | = | 100 | × | 3,372 | ÷ | 14,415 |
Basado en informes: 10-K (fecha de reporte: 2021-12-31), 10-K (fecha de reporte: 2020-12-31), 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).
1 US$ en millones
Comparación con los competidores
Abbott Laboratories, ROE, tendencias a largo plazo, comparación con los competidores
| Abbott Laboratories | Bristol-Myers Squibb Co. | Cigna Corp. | CVS Health Corp. | Danaher Corp. | Elevance Health Inc. | Humana Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 dic. 2021 | 19.75% | 19.46% | 11.39% | 10.54% | 14.24% | 16.93% | 18.24% | 14.32% | 7.01% | 24.09% |
| 31 dic. 2020 | 13.71% | -23.84% | 16.81% | 10.35% | 9.17% | 13.77% | 24.53% | 10.90% | 9.44% | 23.52% |
| 31 dic. 2019 | 11.86% | 6.66% | 11.26% | 10.39% | 9.94% | 15.15% | 22.49% | 16.69% | 9.25% | 24.02% |
| 31 dic. 2018 | 7.76% | 35.07% | 6.43% | -1.02% | 9.40% | 13.14% | 16.56% | 16.89% | 6.12% | 23.19% |
| 31 dic. 2017 | 1.54% | 8.58% | 16.32% | 17.57% | 9.45% | 14.50% | 24.87% | 13.97% | 8.01% | 22.10% |
| 31 dic. 2016 | 6.82% | 27.55% | 13.60% | 14.44% | 11.10% | 9.84% | 5.75% | 12.74% | 6.80% | 18.33% |
| 31 dic. 2015 | 20.85% | 10.97% | 17.40% | 14.08% | 14.17% | 11.11% | 12.33% | 13.63% | 5.03% | 17.18% |
| 31 dic. 2014 | 10.61% | 13.49% | 19.51% | 12.23% | 11.11% | 10.60% | 11.89% | 12.39% | 15.76% | 17.31% |
| 31 dic. 2013 | 10.23% | 16.91% | 13.97% | 12.10% | 12.04% | 10.05% | 13.21% | 19.16% | 18.57% | 17.50% |
| 31 dic. 2012 | 22.32% | 14.39% | 16.61% | 10.28% | 12.58% | 11.16% | 13.81% | 18.34% | 21.14% | 17.72% |
| 31 dic. 2011 | 19.35% | 23.25% | 15.90% | 9.10% | 12.85% | 11.36% | 17.60% | 18.71% | 19.39% | 18.17% |
| 31 dic. 2010 | 20.66% | 19.74% | 20.24% | 9.09% | 13.08% | 12.12% | 15.88% | 18.74% | 21.18% | 17.94% |
| 31 dic. 2009 | 25.14% | 71.49% | 24.04% | 10.33% | 9.90% | 19.09% | 18.00% | 15.13% | 16.88% | 16.19% |
| 31 dic. 2008 | 27.92% | 42.86% | 8.13% | 9.29% | 13.43% | 11.62% | 14.52% | 16.13% | 19.34% | 14.33% |
| 31 dic. 2007 | 20.28% | 20.50% | 23.48% | 8.42% | 15.08% | 14.55% | 20.69% | 16.26% | 25.53% | 23.20% |
| 31 dic. 2006 | 12.22% | 15.86% | 26.67% | 13.80% | 16.89% | 12.59% | 15.96% | 12.22% | 27.14% | 19.99% |
| 31 dic. 2005 | 23.39% | 26.77% | 30.32% | 14.70% | 17.67% | 9.86% | 12.47% | 21.27% | 17.26% | 18.61% |
Basado en informes: 10-K (fecha de reporte: 2021-12-31), 10-K (fecha de reporte: 2020-12-31), 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).
Comparación con el sector industrial: Equipos y servicios de atención médica
Abbott Laboratories, ROE, tendencias a largo plazo, comparación con el sector industrial: equipos y servicios de atención médica
| Abbott Laboratories | Equipos y servicios de atención médica | |
|---|---|---|
| 31 dic. 2021 | 19.75% | 15.34% |
| 31 dic. 2020 | 13.71% | 10.91% |
| 31 dic. 2019 | 11.86% | 12.89% |
| 31 dic. 2018 | 7.76% | 10.52% |
| 31 dic. 2017 | 1.54% | 13.24% |
| 31 dic. 2016 | 6.82% | 12.38% |
| 31 dic. 2015 | 20.85% | 12.69% |
| 31 dic. 2014 | 10.61% | 13.38% |
| 31 dic. 2013 | 10.23% | 13.72% |
| 31 dic. 2012 | 22.32% | 15.41% |
| 31 dic. 2011 | 19.35% | 15.50% |
| 31 dic. 2010 | 20.66% | 15.58% |
| 31 dic. 2009 | 25.14% | 21.69% |
| 31 dic. 2008 | 27.92% | 17.13% |
| 31 dic. 2007 | 20.28% | 17.12% |
| 31 dic. 2006 | 12.22% | 16.75% |
| 31 dic. 2005 | 23.39% | 18.00% |
Basado en informes: 10-K (fecha de reporte: 2021-12-31), 10-K (fecha de reporte: 2020-12-31), 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).
Comparación con la industria: Atención médica
Abbott Laboratories, ROE, tendencias a largo plazo, comparación con la industria: atención médica
| Abbott Laboratories | Atención médica | |
|---|---|---|
| 31 dic. 2021 | 19.75% | 23.41% |
| 31 dic. 2020 | 13.71% | 15.98% |
| 31 dic. 2019 | 11.86% | 20.82% |
| 31 dic. 2018 | 7.76% | 16.81% |
| 31 dic. 2017 | 1.54% | 13.91% |
| 31 dic. 2016 | 6.82% | 15.77% |
| 31 dic. 2015 | 20.85% | 15.13% |
| 31 dic. 2014 | 10.61% | 16.65% |
| 31 dic. 2013 | 10.23% | 17.97% |
| 31 dic. 2012 | 22.32% | 17.14% |
| 31 dic. 2011 | 19.35% | 15.00% |
| 31 dic. 2010 | 20.66% | 14.19% |
| 31 dic. 2009 | 25.14% | 19.22% |
| 31 dic. 2008 | 27.92% | 18.61% |
| 31 dic. 2007 | 20.28% | 16.90% |
| 31 dic. 2006 | 12.22% | 21.03% |
| 31 dic. 2005 | 23.39% | 18.40% |
Basado en informes: 10-K (fecha de reporte: 2021-12-31), 10-K (fecha de reporte: 2020-12-31), 10-K (fecha de reporte: 2019-12-31), 10-K (fecha de reporte: 2018-12-31), 10-K (fecha de reporte: 2017-12-31), 10-K (fecha de reporte: 2016-12-31), 10-K (fecha de reporte: 2015-12-31), 10-K (fecha de reporte: 2014-12-31), 10-K (fecha de reporte: 2013-12-31), 10-K (fecha de reporte: 2012-12-31), 10-K (fecha de reporte: 2011-12-31), 10-K (fecha de reporte: 2010-12-31), 10-K (fecha de reporte: 2009-12-31), 10-K (fecha de reporte: 2008-12-31), 10-K (fecha de reporte: 2007-12-31), 10-K (fecha de reporte: 2006-12-31), 10-K (fecha de reporte: 2005-12-31).